Johnson LV - Search Results

1

The human retina and retinal pigment epithelium are abundant sources of vitronectin mRNA.

Ozaki S, Johnson LV, Mullins RF, Hageman GS, Anderson DH. Ozaki S, et al. Among authors: johnson lv. Biochem Biophys Res Commun. 1999 May 19;258(3):524-9. doi: 10.1006/bbrc.1999.0672. Biochem Biophys Res Commun. 1999. PMID: 10329419

2

A role for local inflammation in the formation of drusen in the aging eye.

Anderson DH, Mullins RF, Hageman GS, Johnson LV. Anderson DH, et al. Among authors: johnson lv. Am J Ophthalmol. 2002 Sep;134(3):411-31. doi: 10.1016/s0002-9394(02)01624-0. Am J Ophthalmol. 2002. PMID: 12208254 Review.

3

Vitronectin gene expression in the adult human retina.

Anderson DH, Hageman GS, Mullins RF, Neitz M, Neitz J, Ozaki S, Preissner KT, Johnson LV. Anderson DH, et al. Among authors: johnson lv. Invest Ophthalmol Vis Sci. 1999 Dec;40(13):3305-15. Invest Ophthalmol Vis Sci. 1999. PMID: 10586957

4

A potential role for immune complex pathogenesis in drusen formation.

Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH. Johnson LV, et al. Exp Eye Res. 2000 Apr;70(4):441-9. doi: 10.1006/exer.1999.0798. Exp Eye Res. 2000. PMID: 10865992

5

Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation.

Anderson DH, Ozaki S, Nealon M, Neitz J, Mullins RF, Hageman GS, Johnson LV. Anderson DH, et al. Among authors: johnson lv. Am J Ophthalmol. 2001 Jun;131(6):767-81. doi: 10.1016/s0002-9394(00)00961-2. Am J Ophthalmol. 2001. PMID: 11384575

6

Vitronectin receptor expression and distribution at the photoreceptor-retinal pigment epithelial interface.

Anderson DH, Johnson LV, Hageman GS. Anderson DH, et al. Among authors: johnson lv. J Comp Neurol. 1995 Sep 11;360(1):1-16. doi: 10.1002/cne.903600102. J Comp Neurol. 1995. PMID: 7499556

7

Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration.

Leu ST, Batni S, Radeke MJ, Johnson LV, Anderson DH, Clegg DO. Leu ST, et al. Among authors: johnson lv. Exp Eye Res. 2002 Jan;74(1):141-54. doi: 10.1006/exer.2001.1112. Exp Eye Res. 2002. PMID: 11878827

8

The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.

Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. Johnson LV, et al. Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11830-5. doi: 10.1073/pnas.192203399. Epub 2002 Aug 20. Proc Natl Acad Sci U S A. 2002. PMID: 12189211 Free PMC article.

9

Drusen-associated degeneration in the retina.

Johnson PT, Lewis GP, Talaga KC, Brown MN, Kappel PJ, Fisher SK, Anderson DH, Johnson LV. Johnson PT, et al. Among authors: johnson lv. Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4481-8. doi: 10.1167/iovs.03-0436. Invest Ophthalmol Vis Sci. 2003. PMID: 14507896

10

Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration.

Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV. Anderson DH, et al. Among authors: johnson lv. Exp Eye Res. 2004 Feb;78(2):243-56. doi: 10.1016/j.exer.2003.10.011. Exp Eye Res. 2004. PMID: 14729357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page